MedTrace Logo

Measurement of Respiratory Admittance for Pediatric Asthma Diagnosis

NCT02877537 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 177

Last updated 2016-08-24

No results posted yet for this study

Summary

The purpose is to characterize the change of respiratory admittance induced by salbutamol inhalation in children and young adults. A variation threshold will be fixed to distinguish asthmatic and healthy subjects.

This project could allow a better identification of asthmatic individuals needing a treatment, a reduction of morbidity of asthma, a reduction of unnecessary treatments administered in individuals with respiratory but not asthmatic symptoms, a better comprehension of bronchial hyperreactivity and its role in asthmatic disease.

Conditions

Interventions

DRUG

Salbutamol

bronchodilation obtained with 2 inhalations of salbutamol (100 µg per dose) with inhalation chamber

PROCEDURE

Forced oscillation technique

before and after bronchodilation

PROCEDURE

Plethysmography

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • François MARCHAL · CHU de Nancy - Hôpital BRABOIS Enfants - Explorations fonctionnelles pédiatriques

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02877537 on ClinicalTrials.gov